Anti-Hypertensive Potential and Epigenetics of Angiotensin II type 2 Receptor (AT2R)

(E-pub Ahead of Print)

Author(s): Mayank Chaudhary*

Journal Name: Current Hypertension Reviews

Become EABM
Become Reviewer
Call for Editor


Background: Renin angiotensin system (RAS) is a critical pathway involved in blood pressure regulation. Octapeptide, angiotensin II (Ang aII), is biologically active compound of RAS pathway which mediates its action by binding to either angiotensin II type 1 receptor (AT1R) or angiotensin II type 2 receptor (AT2R). Binding of Ang II to AT1R facilitates blood pressure regulation whereas AT2R is primarily involved in wound healing and tissue remodelling.

Objective: Recent studies have highlighted additional role of AT2R to counter balance detrimental effects of AT1R. Activation of angiotensin II type 2 receptor using AT2R agonist has shown effect on natriuresis and release of nitric oxide. Additionally, AT2R activation has been found to inhibit angiotensin converting enzyme (ACE) and enhance angiotensin receptor blocker (ARB) activity. These findings highlight the potential of AT2R as novel therapeutic target against hypertension.

Conclusion: The potential role of AT2R highlights the importance of exploring additional mechanisms that might be crucial for AT2R expression. Epigenetic mechanisms including DNA methylation and histone modification have been explored vastly with relation to cancer but role of such mechanisms on expression of AT2R has recently gained interest.

Keywords: Epigenetics. DNA methylation, Hypertension, Angiotensin II type 2 receptorEpigenetics. DNA methylation, Hypertension, Angiotensin II type 2 receptor

Rights & PermissionsPrintExport Cite as

Article Details

Published on: 09 December, 2020
(E-pub Ahead of Print)
DOI: 10.2174/1573402116999201209203015
Price: $95

Article Metrics

PDF: 218